1. Home
  2. IHRT vs VYGR Comparison

IHRT vs VYGR Comparison

Compare IHRT & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHeartMedia Inc.

IHRT

iHeartMedia Inc.

HOLD

Current Price

$2.35

Market Cap

589.5M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$2.88

Market Cap

193.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHRT
VYGR
Founded
1974
2013
Country
United States
United States
Employees
N/A
141
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
589.5M
193.5M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
IHRT
VYGR
Price
$2.35
$2.88
Analyst Decision
Sell
Strong Buy
Analyst Count
2
2
Target Price
$4.25
$16.50
AVG Volume (30 Days)
432.7K
373.2K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
54.19
N/A
EPS
N/A
N/A
Revenue
$3,864,991,000.00
$10,135,000.00
Revenue This Year
$9.96
$34.04
Revenue Next Year
N/A
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
0.27
N/A
52 Week Low
$2.32
$2.94
52 Week High
$6.56
$5.55

Technical Indicators

Market Signals
Indicator
IHRT
VYGR
Relative Strength Index (RSI) N/A 42.48
Support Level N/A $2.96
Resistance Level N/A $3.30
Average True Range (ATR) 0.00 0.12
MACD 0.00 -0.02
Stochastic Oscillator 0.00 26.72

Price Performance

Historical Comparison
IHRT
VYGR

About IHRT iHeartMedia Inc.

iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: